The Latest Breaking News from FDA

Why Ketamine-Assisted Psychotherapy May Be The New Vanguard Of SUD Treatment

By Peter Loeb, CEO of Lionrock

Benzinga · Jul 25, 2022

My Baby Needed Special Formula From Europe. U.S. Trade Policy Made It Almost Unobtainable.

The FDA should not stand in the way of parents doing what’s best for their children.

Reason · Jul 25, 2022

5 things to know about the FDA's flawed approach to accelerated drug approvals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

WEKU · Jul 25, 2022

How the pandemic set back drug safety

The best form of inspection is an unannounced one, but the pandemic changed the game for regulators. They’ll need to work together to protect consumers.

360info · Jul 25, 2022

Monkeypox has been declared a global emergency. Should you get a vaccine? And which one?

Should you get a monkeypox vaccine?

Miami Herald · Jul 23, 2022

Critical elements of leading Alzheimer’s study possibly fraudulent

The highly influential paper, first published in 2006, has helped guide billions of dollars in US federal research into the disease

The Guardian - US · Jul 23, 2022

Paxlovid going underused due to doctors’ ‘misperceptions’, experts say

Clinicians are ‘skittish’ about the Covid antiviral, resulting in a failure to treat patients who could greatly benefit

The Guardian - US · Jul 23, 2022

Recap Of Friday's Biotech Catalysts - End Of The Day Summary

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and relatlimab) for treatment of patients with Unresectable or Metastatic Melanoma based on results from the Phase 2/3 RELATIVITY-047 trial. Bristol Myers shares traded in a range of $72.48 to $73.61 on a…

Benzinga · Jul 22, 2022

Overturning Roe leaves people with autoimmune conditions in danger

People with inflammatory arthritis like rheumatoid arthritis are having trouble getting methotrexate in the wake of abortion bans.

Inverse · Jul 22, 2022

A Skittles lawsuit raises questions over titanium dioxide — a legal food additive

A suit has been filed against the maker of Skittles over titanium dioxide, a color additive that has been on the market for decades but which has been banned in food by European authorities.

WEKU · Jul 22, 2022